Welcome to Paid Research Studies




  • Condition:   Congenital Cataract
    Interventions:   Procedure: minimal invasive surgery and secondary IOL implantation;   Procedure: traditional cataract surgery and secondary IOL implantation
    Sponsor:   Sun Yat-sen University
    Recruiting

  • Conditions:   Endophthalmitis;   Cataracts Infantile;   Suture, Complication
    Interventions:   Device: Vicryl suture;   Device: Nylon suture
    Sponsor:   University of Campinas, Brazil
    Recruiting

  • Conditions:   Pediatric Cataract;   Congenital Cataract;   Traumatic Cataract;   Visual Outcome;   Genetic Anticipation
    Intervention:  
    Sponsors:   Evidence Based Cataract Study Group;   Eye & ENT Hospital of Fudan University
    Recruiting

  • Conditions:   Burkitt Lymphoma;   Retinoblastoma
    Intervention:   Other: mHealth Case Management System
    Sponsors:   Duke University;   National Cancer Institute (NCI)
    Not yet recruiting

  • Conditions:   Pediatric Retinoblastoma;   Retinoblastoma
    Interventions:   Other: Wechsler Intelligence Scale for Children, Fifth Edition (WISC-V);   Other: California Verbal Learning Test, Children's Version;   Other: Beery Developmental Test of Visual Motor Integration, 6th edition;   Other: Grooved Pegboard Test;   Other: Behavior Assessment System for Children/Parent Report
    Sponsor:   Memorial Sloan Kettering Cancer Center
    Recruiting

  • Conditions:   Sarcoma;   Endocrine Tumors;   Neuroblastoma;   Retinoblastoma;   Renal Cancer
    Intervention:  
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Wolfram Syndrome;   Diabetes Mellitus;   Optic Nerve Atrophy;   Ataxia
    Intervention:   Drug: dantrolene sodium
    Sponsors:   Washington University School of Medicine;   National Institutes of Health (NIH)
    Recruiting

  • Conditions:   Glioma;   Neuroectodermal Tumors, Primitive;   Wilms Tumor;   Rhabdomyosarcoma;   Sarcoma, Ewing;   Osteosarcoma;   Retinoblastoma
    Interventions:   Drug: Metronomic Cyclophosphamide;   Drug: Thalidomide
    Sponsor:   Washington University School of Medicine
    Recruiting

  • Conditions:   Retinoblastoma;   Clear Cell Sarcoma;   Renal Cell Carcinoma;   Rhabdoid Tumor;   Wilms Tumor;   Hepatoblastoma;   Neuroblastoma;   Germ Cell Tumors;   Ewings Sarcoma;   Non-rhabdomyosarcoma Soft Tissue Sarcoma;   Osteosarcoma;   Rhabdomyosarcoma
    Interventions:   Drug: Simvastatin;   Drug: Cyclophosphamide;   Drug: Topotecan;   Drug: Myeloid growth factor
    Sponsors:   Emory University;   Children's Healthcare of Atlanta
    Recruiting

  • Conditions:   Neuromyelitis Optica;   NMO Spectrum Disorder
    Intervention:  
    Sponsors:   Mayo Clinic;   Alexion Pharmaceuticals
    Recruiting

  • Conditions:   Pilomyxoid Astrocytoma;   Pilocytic Astrocytoma;   Glioma, Astrocytic;   Optic Nerve Glioma;   Pleomorphic Xanthoastrocytoma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Gliosarcoma;   Diffuse Intrinsic Pontine Glioma;   DIPG;   Low-grade Glioma;   Brainstem Glioma
    Interventions:   Drug: Mebendazole;   Drug: Vincristine;   Drug: Carboplatin;   Drug: Temozolomide;   Drug: Bevacizumab;   Drug: Irinotecan
    Sponsors:   Julie Krystal;   Janssen Pharmaceuticals
    Recruiting

  • Conditions:   Brain Stem Neoplasm;   Pineal Region Neoplasm;   Recurrent Central Nervous System Neoplasm;   Recurrent Lymphoma;   Recurrent Malignant Solid Neoplasm;   Recurrent Visual Pathway Glioma;   Refractory Central Nervous System Neoplasm;   Refractory Lymphoma;   Refractory Malignant Solid Neoplasm;   Refractory Visual Pathway Glioma
    Interventions:   Drug: Entinostat;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Glioma;   Pilocytic Astrocytoma;   Anaplastic Astrocytoma;   Glioblastoma;   Mixed Oligoastrocytoma;   Mixed Glioma;   Oligodendroglioma;   Optic Glioma;   Astrocytoma
    Interventions:   Device: MRI-guided laser ablation;   Drug: Doxorubicin;   Drug: Etoposide;   Device: Dynamic contrast-enhanced (DCE) MRI;   Device: Dynamic susceptibility contrast (DSC) MRI
    Sponsor:   Washington University School of Medicine
    Recruiting

  • Condition:   Leber Congenital Amaurosis 10
    Intervention:   Drug: AGN-151587
    Sponsors:   Allergan;   Editas Medicine, Inc.
    Not yet recruiting

  • Conditions:   Pediatric Solid Tumor;   Germ Cell Tumor;   Retinoblastoma;   Hepatoblastoma;   Wilms Tumor;   Rhabdoid Tumor;   Carcinoma;   Osteosarcoma;   Ewing Sarcoma;   Rhabdomyosarcoma;   Synovial Sarcoma;   Clear Cell Sarcoma;   Malignant Peripheral Nerve Sheath Tumors;   Desmoplastic Small Round Cell Tumor;   Soft Tissue Sarcoma;   Neuroblastoma
    Interventions:   Biological: second generation 4-1BBζ EGFR806-EGFRt;   Biological: second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
    Sponsor:   Seattle Children's Hospital
    Recruiting

  • Conditions:   Amblyopia;   Strabismus
    Intervention:   Device: Retinal Birefringence Imager
    Sponsors:   Rebiscan, Inc.;   Retina Foundation of the Southwest
    Not yet recruiting

  • Conditions:   Low Grade Glioma;   Recurrent Childhood Pilocytic Astrocytoma;   Recurrent Neurofibromatosis Type 1;   Recurrent Visual Pathway Glioma;   Refractory Neurofibromatosis Type 1;   Refractory Visual Pathway Glioma
    Interventions:   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Selumetinib
    Sponsor:   National Cancer Institute (NCI)
    Recruiting